Skip to content

Public FDA record

Z-2212-2023: UFSK Treatment chair 500 XLE- Treatment chair for positioning and support of the patient during diagnosti

Recall record Z-2212-2023 for UFSK - International OSYS Gmbh. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2212-2023
Company in FDA record
UFSK - International OSYS Gmbh
FDA classification date
Jul 20, 2023
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Service life of the electrical seat part drive of the treatment chair may be shortened unexpectedly after several years of use due to a potential wear-related reduction in the self-locking of the drive and may remain undetected. A worsened self-locking of the seat drive can lead to overriding the drive s end position when positioning the patient with the seat part in an inclined position

Source facts

Action
UFSK email issued to distributors on May 3, 2023 action to take: 1a) distributor has to check their stock and quarantine affected chairs 1b) distributor has to identify customers who received treatment chairs with affected serial numbers 1c) distributor has to confirm via reply form to UFSK, that he has received and understood the action and will forward the safety notice to his customers. Distributors issued Urgent Medical Device Correction via email to Customers on May 31, 2023. Letter states reason for recall, health risk and action to take: Restricted use instructions as follows: The seat part drive is to be retracted so far with the patient in position that the seat part is in a horizontal position. Then the seat part may no longer be adjusted with the positioned patient. Attach the safety notice to the instructions for use of the respective treatment chair. Label the treatment chair appropriately using the information in the attachment to ensure safe use by changing users. If the seat drive is replaced, the backward inclination of the seat section can be used again. Follow-up measures: 7a) We urgently recommend to replace the seat part drive at the latest when the next safety inspection is carried out (interval 12 months). A replacement drive can be installed easily and without great effort. The successor model of the drive has a technically advanced self-locking mechanism for the motor and a mechanical end stop. The risk of the seat drive overrunning its end position due to wear when the seat section is tilted is then absolutely minimized. 7b) Update 500 XLE user & service manual with enclosed supplement. New contents: service plan for safety-relevant component, amended spare part list and installation instructions for the spare part drive. see document attached: Add_Manual_97000017_500XLE_SN2000-4506_40002535_230530_EN.pdf. Please contact UFSK-OSYS authorized US-Importer and distributor: Nautilus Surgical Inc., 2520 Horse Pasture Road Suite 103, Virgini
Initiated
2023-05-31
Root cause
Device Design
Distribution
Nationwide
Recall number
Z-2212-2023
Recall status
Open, Classified
CDRH record ID
201318
FDA classified
2023-07-20
Recall event number
92534

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗